Damn is about to burst, financial pressure on these hospitals is so great in high risk patients like COPD they are desperate for solutions.
Wheezo has a monopoly for asthma and COPD in RPM patient population, especially regarding hospital re-admission.
RSH just has to execute and deliver and this will explode.
Ann: wheezo RPM program selected by leading USA heart center, page-5
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
-0.006(6.90%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 8.7¢ | 8.1¢ | $67.85K | 805.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 147498 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 400000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| RSH (ASX) Chart |